St. Louis synthetic blood startup raises $800,000

St. Louis synthetic blood startup raises $800,000

St. Louis synthetic blood startup raises $800,000 St. Louis Business Journal By Brian Robbins June 4, 2018, 2:41 pm A biotech startup that is developing bio-synthetic hybrid red blood cells has raised $800,000 from investors, according to a Securities and Exchange...
Wash U continues quest to develop artificial blood

Wash U continues quest to develop artificial blood

Wash U continues quest to develop artificial blood By Shahla Farzan Apr 13, 2018 Thousands of people in the United States die each year due to severe blood loss, often before they reach an emergency room. To help reduce the number of trauma deaths, a Washington...
$5 million aids development of artificial red blood cells

$5 million aids development of artificial red blood cells

$5 million aids development of artificial red blood cells Research focused on preventing deaths from traumatic bleeding Washington University in St. Louis By Kristina Sauerwein  February 27, 2018 Trauma is the leading cause of death for Americans under the age of 46....
Erythromer, a nanoscale bio-synthetic artificial red cell

Erythromer, a nanoscale bio-synthetic artificial red cell

Erythromer, a nanoscale bio-synthetic artificial red cell VJHemOnc Video Journal of Hematological Oncology Published on Dec 16, 2016 Press brief by Allan Doctor, MD of Washington University School of Medicine, St. Louis, MO, on erythromer (EM), a nanoscale...
Video: Artificial blood cells clear first phase of animal testing

Video: Artificial blood cells clear first phase of animal testing

Video: Artificial blood cells clear first phase of animal testing SAN DIEGO | An artificial red blood cell has come close to emulating the key functions of natural cells and does not appear to be associated with the side effects such as vasospasm and poor response to...